Related Experiment Video
Updated: Jun 12, 2026

06:32
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
ACR appropriateness criteria on metastatic bone disease
Catherine C Roberts1, Richard H Daffner, Barbara N Weissman
1Mayo Clinic, Phoenix, Arizona 85054, USA.
Journal of the American College of Radiology : JACR
|June 5, 2010
Summary
Selecting the best bone metastasis imaging techniques depends on the specific cancer and clinical situation. No single method is universally superior for screening, staging, or surveillance of bone metastases.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Metastatic disease to bone is a common complication of various cancers.
- Accurate imaging is crucial for patient management, including screening, staging, and surveillance.
- Multiple imaging modalities exist, each with potential benefits and limitations.
Purpose of the Study:
- To provide evidence-based recommendations for the appropriate use of imaging in patients with suspected or documented metastatic bone disease.
- To review clinical scenarios involving various cancer types and stages.
- To guide clinicians in selecting the most suitable imaging modality for specific situations.
Main Methods:
- The ACR Appropriateness Criteria((R)) Expert Panel on Musculoskeletal Radiology reviewed clinical scenarios.
- Evidence-based consensus was reached on the utility of various imaging modalities.
- Modalities considered include bone scintigraphy ((99m)Tc), MRI, CT, radiography, and PET scans.
Main Results:
- No single imaging modality is consistently optimal for all patients with bone metastases.
- The choice of imaging depends on the specific tumor type, stage, and clinical presentation.
- In certain cases, imaging may not be indicated.
Conclusions:
- Tailored imaging selection is essential for effective management of metastatic bone disease.
- Recommendations address diverse scenarios, from early-stage breast cancer to multiple myeloma and osteosarcoma.
- A case-by-case approach, guided by evidence-based criteria, ensures appropriate use of imaging resources.